"The Abben Cancer Center of Spencer Hospital provides you compassionate, comprehensive oncology services and support for your health journey."

During the past decade, Abben Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Abben Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "University of Nebraska" with 2 trials sponsored, "GOG Foundation" with 1 trials sponsored, "Gynecologic Oncology Group" with 1 trials sponsored and "SWOG Cancer Research Network" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Abben Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Abben Cancer Center" are "Breast Cancer" (3 trials), "Anal Cancer" (1 trials), "Anemia" (1 trials), "Bile Duct Cancer" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Abben Cancer Center" in a lesser frequency.

Most popular intervention types in "Abben Cancer Center" are "Other" (7 trials), "Drug" (6 trials), "Biological" (3 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (5 trials), "Laboratory Biomarker Analysis" (4 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials) and "Ibrutinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Abben Cancer Center" are 5 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Abben Cancer Center". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Abben Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Abben Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".